'''<big>Adverse effects by incidence:</big>'''<ref name = TGA>{{cite web|title=ZonegranÂ® Product Information|work=TGA eBusiness Services|publisher=SciGen (Australia) Pty Ltd|date=4 April 2013|accessdate=18 November 2013|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2011-PI-02002-3|format=PDF}}</ref><ref>{{cite web|title=Zonegran 25, 50, 100 mg Hard Capsules|work=electronic Medicines Compendium|date=8 October 2013|accessdate=18 November 2013|url=http://www.medicines.org.uk/emc/medicine/16240/SPC/Zonegran+25%2c+50%2c+100+mg+Hard+Capsules/|publisher=Eisai Ltd}}</ref><ref name = MSR>{{cite web|title=zonisamide (Rx) - Zonegran|work=Medscape Reference|publisher=WebMD|accessdate=18 November 2013|url=http://reference.medscape.com/drug/zonegran-zonisamide-343025}}</ref>

 


 
'''Very common (>10% incidence) adverse effects include:'''

 
{{colbegin|4}}

 
* [[Anorexia (symptom)|Anorexia]]

 
* [[Somnolence]]

 
* Dizziness

 
* Agitation

 
* Irritability

 
* Confusional state

 
* Depression

 
* Diplopia

 
* Memory impairment

 
* Decreased bicarbonate

 
{{colend}}

 


 
'''Common (1-10% incidence) adverse effects include:'''

 


 
{{colbegin|3}}

 


 
* Ecchymosis

 
* Hypersensitivity

 
* Affect lability

 
* Anxiety

 
* Insomnia

 
* Psychotic disorder

 
* Bradyphrenia

 
* Disturbance in attention

 
* Nystagmus

 
* Paraesthesia

 
* Speech disorder

 
* Tremor

 
* Abdominal pain

 
* Constipation

 
* Diarrhoea

 
* Dyspepsia

 
* Nausea

 
* Rash

 
* Pruritus

 
* Alopecia

 
* Nephrolithiasis

 
* Fatigue

 
* Influenza-like illness

 
* Pyrexia

 
* Oedema peripheral

 
* Weight loss

 
{{colend}}

 

